Bispecific antigen-binding constructs targeting Her2
US11325981B2 · kind B2 · utility
1Cited by
33References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2018 |
| Grant date | May 10, 2022 |
| Priority date | — |
| Expiry date | Nov 8, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are biparatopic antigen-binding constructs that specifically bind HER2. The biparatopic antigen-binding constructs comprise one antigen-binding moiety that binds to ECD2 of HER2, a second antigen-binding moiety that binds to ECD4 of HER2, and an Fc. At least one of the antigen-binding moieties is an scFv. The biparatopic antigen-binding constructs can be used in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.